Moneycontrol
Get App
Last Updated : Feb 09, 2012 04:00 PM IST | Source: CNBC-TV18

ANDAs will benefit FY13 and FY14 numbers: Alembic Pharma

Alembic Pharma has announced its third quarter results. Pranav Amin, director of Alembic Pharma says, the revenues have gone up 15%, YoY. He further says, the company so far has filed 41 abbreviated new drug applications (ANDAs). “Over the next couple of years, we should see quite a bit of growth coming in international generic,” he adds.


Alembic Pharma has announced its third quarter results. Pranav Amin, director of Alembic Pharma says, the revenues have gone up 15% to Rs 383 crore from Rs 332 crore last year.


He further says, the company so far has filed 41 abbreviated new drug applications (ANDAs).

Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.

First Published on Feb 9, 2012 02:16 pm